OSGEN PHARMACEUTICALS LIMITED

Active Hemel Hempstead

Manufacture of basic pharmaceutical products

2 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
O

OSGEN PHARMACEUTICALS LIMITED

Manufacture of basic pharmaceutical products

Founded 9 Apr 2016 Active Hemel Hempstead, England 2 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 29 Dec 2025 Next due 30 Dec 2026 7 months remaining
Confirmation Submitted 11 Mar 2026 Next due 25 Mar 2027 9 months remaining
Net assets £-3M £383K 2024 year on year
Total assets £686K £326K 2024 year on year
Total Liabilities £4M £709K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Unit 2 Cleveland Way Hemel Hempstead Industrial Estate Hemel Hempstead HP2 7DL England

Email

info@example.com

Website

www.example.com

Full company profile for OSGEN PHARMACEUTICALS LIMITED (10113998), an active life sciences and medical technology company based in Hemel Hempstead, England. Incorporated 9 Apr 2016. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type micro-entity
Next accounts 30 Mar 2026
Due by 30 Dec 2026 7 months remaining

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

N/A

Net Assets

-£3.15M

Decreased by £382.81k (-14%)

Total Liabilities

£3.83M

Increased by £709.21k (+23%)

Turnover

N/A

Employees

2

Debt Ratio

559%

Decreased by 311 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
30 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Patel, AnishDirectorBritishEngland309 Apr 2016Active
Patel, MikeshDirectorBritishEngland359 Apr 2016Active

Shareholders

Shareholders (2)

Huntly Holdings Ltd
98.0%
Nutal Patel
2.0%

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Huntly Holdings Ltd

Unknown

Active
Notified 1 Oct 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Anish Patel

British

Active
Notified 5 Jul 2016
Residence England
DOB June 1995
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Mikesh Patel

British

Active
Notified 11 Sept 2016
Residence England
DOB July 1990
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

OSGEN PHARMACEUTICALS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Mar 2026Confirmation StatementConfirmation statement made on 11 Mar 2026 with no updates
29 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
10 Oct 2025Persons With Significant ControlHuntly Holdings Ltd notified as a person with significant control
10 Oct 2025Persons With Significant ControlCessation of Anish Patel as a person with significant control on 1 Oct 2025
15 Apr 2025Confirmation StatementConfirmation statement made on 11 Mar 2025 with no updates
11 Mar 2026 Confirmation Statement

Confirmation statement made on 11 Mar 2026 with no updates

29 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

10 Oct 2025 Persons With Significant Control

Huntly Holdings Ltd notified as a person with significant control

10 Oct 2025 Persons With Significant Control

Cessation of Anish Patel as a person with significant control on 1 Oct 2025

15 Apr 2025 Confirmation Statement

Confirmation statement made on 11 Mar 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 11 Mar 2026 with no updates

2 months ago on 11 Mar 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 29 Dec 2025

Huntly Holdings Ltd notified as a person with significant control

7 months ago on 10 Oct 2025

Cessation of Anish Patel as a person with significant control on 1 Oct 2025

7 months ago on 10 Oct 2025

Confirmation statement made on 11 Mar 2025 with no updates

1 years ago on 15 Apr 2025